I now have all the content I need from K Park's textbook. Let me compile a comprehensive, exam-ready 5-mark answer.
VITAMIN A DEFICIENCY
(K. Park's Textbook of Preventive and Social Medicine, 28th Edition)
Definition
Vitamin A (Retinol) is a fat-soluble vitamin essential for vision, epithelial integrity, growth, and immunity. Its deficiency leads to a spectrum of ocular and extra-ocular manifestations collectively called Xerophthalmia.
1 IU of Vitamin A = 0.3 mcg of Retinol
1 Retinol Equivalent (RE) = 3.333 IU of Vitamin A
Sources of Vitamin A
| Animal Sources (Pre-formed Retinol) | Plant Sources (Pro-vitamin / Carotenoids) |
|---|
| Liver (ox) - 16,500 RE/100g | Carrot - 1,167 RE/100g |
| Butter, Cheese, Eggs | Spinach, Amaranth, Dark green leafy vegetables |
| Whole milk, Fish | Mango, Papaya, Pumpkin |
| Fish liver oils (richest source) | Yellow/orange fruits & vegetables |
Note: The liver stores Vitamin A (as retinol palmitate) for 6-9 months. Carotene conversion to Vitamin A is impaired in malnourished children and those with diarrhoea.
Functions of Vitamin A
- Vision - Essential for production of retinal pigments needed for dim-light (scotopic) vision
- Epithelial integrity - Maintains normal functioning of glandular and epithelial tissue lining intestinal, respiratory, and urinary tracts
- Growth - Supports skeletal growth
- Anti-infective - Deficiency causes increased susceptibility to infection and lowered immune response
- Anti-cancer - May protect against epithelial cancers (e.g., bronchial carcinoma)
Clinical Features of Vitamin A Deficiency
WHO Classification of Xerophthalmia
┌─────────────────────────────────────────────────────────────┐
│ XEROPHTHALMIA (WHO Classification) │
├──────────────┬──────────────────────────────────────────────┤
│ STAGE │ SIGN │
├──────────────┼──────────────────────────────────────────────┤
│ XN │ Night Blindness │
│ X1A │ Conjunctival Xerosis │
│ X1B │ Bitot's Spots │
│ X2 │ Corneal Xerosis │
│ X3A │ Corneal Ulceration / Keratomalacia (< 1/3) │
│ X3B │ Keratomalacia (≥ 1/3 corneal area) │
│ XS │ Corneal Scar │
│ XF │ Xerophthalmic Fundus │
└──────────────┴──────────────────────────────────────────────┘
FLOWCHART: Progression of Vitamin A Deficiency
VITAMIN A DEFICIENCY
│
▼
┌─── Night Blindness (XN) ────────────────────────────┐
│ (earliest symptom - impaired dark adaptation) │
└─────────────────────────────────────────────────────┘
│
▼
┌─── Conjunctival Xerosis (X1A) ──────────────────────┐
│ Dry, non-wettable, muddy, wrinkled conjunctiva │
│ ("like sand banks at receding tide") │
└─────────────────────────────────────────────────────┘
│
▼
┌─── Bitot's Spots (X1B) ─────────────────────────────┐
│ Triangular, pearly-white/yellowish foamy spots │
│ on bulbar conjunctiva; frequently bilateral │
└─────────────────────────────────────────────────────┘
│
▼
┌─── Corneal Xerosis (X2) ────────────────────────────┐
│ Dull, dry, non-wettable, opaque cornea │
│ May progress to corneal ulceration │
└─────────────────────────────────────────────────────┘
│
▼
┌─── Keratomalacia (X3B) ─────────────────────────────┐
│ ⚠ GRAVE MEDICAL EMERGENCY │
│ Liquefaction/softening of cornea │
│ Cornea may burst → Permanent Blindness │
└─────────────────────────────────────────────────────┘
Extra-Ocular Manifestations
- Follicular hyperkeratosis (skin changes)
- Anorexia and growth retardation
- Increased morbidity and mortality from respiratory and diarrhoeal diseases (even in mild VAD)
Assessment of Vitamin A Deficiency (WHO Prevalence Criteria)
Surveys are done on preschool children (6 months to 6 years) - the highest risk group.
| Criteria | Prevalence Indicating Public Health Problem |
|---|
| Night Blindness (XN) | ≥ 1.0% |
| Bitot's Spots (X1B) | ≥ 0.5% |
| Corneal Xerosis/Ulceration (X2/X3A) | ≥ 0.01% |
| Keratomalacia (X3B) | ≥ 0.01% |
| Corneal Scar (XS) | ≥ 0.05% |
| Serum Retinol < 0.35 µmol/L | ≥ 5% |
Presence of any one criterion is evidence of a xerophthalmia problem in the community.
Vitamin A Deficiency in India
- 5.7% of children in India suffer from eye signs of VAD
- Bitot's spots prevalence exceeds WHO cut-off of 0.8-1.0% in many states
- Only 21% of children aged 12-35 months receive a Vitamin A dose
- States with better coverage: Tamil Nadu (37.2%), Goa (37.3%), Kerala (38.2%), West Bengal (41.2%)
- National Programme for prevention of nutritional blindness was initiated in 1970; modified in 1992; integrated into RCH/NRHM under Tenth Five Year Plan
Treatment
Treat URGENTLY - nearly all early stages are reversible
| Age Group | Dose | Schedule |
|---|
| Children < 6 months | 50,000 IU | Single oral dose |
| Children 6 months - 1 year | 100,000 IU (retinol palmitate) | Day 1 + Day 2 |
| Children > 1 year | 200,000 IU (retinol palmitate) | Day 1 + Day 2 |
All children with corneal ulcers should receive Vitamin A regardless of whether deficiency is suspected.
Prevention and Control
FLOWCHART: Prevention Strategy (Triad)
PREVENTION OF VITAMIN A DEFICIENCY
│
┌───────────────┼───────────────┐
▼ ▼ ▼
SHORT-TERM MEDIUM-TERM LONG-TERM
MEASURES MEASURES MEASURES
│ │ │
Massive dose Food Dietary
Vitamin A fortification diversification,
supplementation (Vanaspati, Nutrition
Margarine, education,
Milk) Breastfeeding,
Infection control,
Immunization
(esp. Measles)
Vitamin A Prophylaxis Programme (National Programme)
| Dose | Age | Schedule |
|---|
| 100,000 IU | 9 months (with measles vaccine) | First dose |
| 200,000 IU | Every 6 months | Up to 5 years of age |
Since Vitamin A can be stored in the body for 6-9 months, a massive dose every 6 months effectively "immunizes" the child against xerophthalmia.
Special situations:
- Children with measles - one dose of Vitamin A (if not received in previous 1 month)
- Children with severe malnutrition - one additional dose of Vitamin A
- Children with xerophthalmia - treated at health facilities
Toxicity (Hypervitaminosis A)
Excess retinol causes: Nausea, vomiting, anorexia, sleep disorders, skin desquamation, enlarged liver, papilloedema.
High carotene intake causes harmless carotenaemia (yellowing of skin/plasma).
Teratogenic effects of massive doses are a concern.
Source: K. Park's Textbook of Preventive and Social Medicine, 28th Edition
Tips to score full marks with this answer:
- Write the WHO classification table neatly - examiners love it
- Use the word "Xerophthalmia" correctly and define it
- Always mention Keratomalacia as a medical emergency
- State the National Programme doses precisely (100,000 IU at 9 months; 200,000 IU every 6 months up to 5 years)
- Mention India-specific data (5.7% prevalence, 1970 programme) - shows command of community medicine
- The WHO prevalence criteria table shows you know the public health aspect which HODs specifically look for